| |
| |
| Exchange: |
Nasdaq National Market |
| Security
Type: |
Common |
| Shares
Out: |
44,215,000 |
| Market
Cap: |
4.11(M) |
| Last
Volume: |
17,424 |
Avg
Vol: |
59,181 |
| 52
Week Range: |
$0.06 - $0.2089 |
|
| Level
I Sector: |
Health Care |
| Level
II Sector: |
Drugs |
| Level
III Sector: |
Biotechnology |
|
Member Indexes:
|
| |
NASDAQ BIOTECHNOLOGY |
|
NASDAQ COMPOSITE |
| |
NASDAQ NNM COMPOSITE |
|
Rankings:
|
|
| Insider 3 Months : - |
| Insider 6 Months : - |
| Insider 3/6 Months : - |
|
| Guru Rank Number : - |
| Guru Rank Value : - |
| Guru Occurances : - |
|
|
|
|
|
| |
|
Company Profile Enzon Pharmaceuticals is engaged in existing licensing arrangements with other companies primarily related to sales of certain drug products that utilize Co.'s proprietary technology. Co. has a marketing agreement relating to the drug Vicineum.
|
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
|
3m +/-:
|
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
|
Actions:
|
|
|
| B |
Buy |
| S |
Sell |
| OE |
Option
Exercised |
| A |
Acquired |
| D |
Disposed |
| AB |
Automatic
Buy |
| AS |
Automatic
Sell |
| IO |
Initial
Ownership |
|
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
| |
| |
Summary (Direct Transactions Only)  |
3 Months |
6 Months |
12 Months |
24 Months |
| Total Shares Bought |
0 |
0 |
99,550 |
99,550 |
| Total Buy Value |
$0 |
$0 |
$13,910 |
$13,910 |
| Total People Bought |
0 |
0 |
1 |
1 |
| Total Buy Transactions |
0 |
0 |
2 |
2 |
| Total Shares Sold |
0 |
0 |
0 |
0 |
| Total Sell Value |
$0 |
$0 |
$0 |
$0 |
| Total People Sold |
0 |
0 |
0 |
0 |
| Total Sell Transactions |
0 |
0 |
0 |
0 |
| End Date |
2024-02-18 |
2023-11-17 |
2023-05-19 |
2022-05-19 |
|
| Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
  Tooman Craig A |
EVP, Finance & CFO |
• – – |
2007-01-17 |
4 |
A |
$0.00 |
$0 |
D/D |
25,000 |
51,000 |
|
- |
|
| Lebuhn Robert |
Director |
– • – |
2007-01-02 |
4 |
OE |
$2.94 |
$117,500 |
D/D |
40,000 |
83,715 |
|
- |
|
| Classon Rolf A |
Director |
– • – |
2006-12-11 |
4 |
S |
$8.23 |
$246,810 |
D/D |
(30,000) |
12,516 |
|
- |
|
| Classon Rolf A |
Director |
– • – |
2006-12-11 |
4 |
OE |
$2.94 |
$88,125 |
D/D |
30,000 |
42,516 |
|
- |
|
| Micati Victor P |
Director |
– • – |
2006-07-01 |
4 |
OE |
$0.00 |
$0 |
D/D |
1,255 |
2,821 |
|
- |
|
| Salisbury Robert C |
Director |
– • – |
2006-07-01 |
4 |
OE |
$0.00 |
$0 |
D/D |
1,255 |
6,852 |
|
- |
|
| Renfro Phillip M |
Director |
– • – |
2006-07-01 |
4 |
OE |
$0.00 |
$0 |
D/D |
1,255 |
3,151 |
|
- |
|
| Lebuhn Robert |
Director |
– • – |
2006-07-01 |
4 |
OE |
$0.00 |
$0 |
D/D |
1,255 |
43,715 |
|
- |
|
| Classon Rolf A |
Director |
– • – |
2006-07-01 |
4 |
OE |
$0.00 |
$0 |
D/D |
1,255 |
12,516 |
|
- |
|
| Ando Goran |
Director |
– • – |
2006-07-01 |
4 |
OE |
$0.00 |
$0 |
D/D |
1,255 |
2,821 |
|
- |
|
| Buchalter Jeffrey H |
Chairman, CEO & President |
• • – |
2006-03-07 |
4 |
B |
$6.81 |
$68,565 |
D/D |
10,000 |
98,234 |
2.81 |
- |
|
| Horak Ivan D |
EVP-R&D & Chief Scien. Officer |
• – – |
2006-03-07 |
4 |
B |
$6.86 |
$20,605 |
D/D |
3,000 |
8,500 |
2.74 |
- |
|
| Tooman Craig A |
Exec VP Finance, CFO |
• – – |
2006-03-07 |
4 |
B |
$6.87 |
$6,868 |
D/D |
1,000 |
26,000 |
2.74 |
- |
|
| Davit Paul Stephen |
Exec. Vice Pres. HR |
• – – |
2005-10-07 |
4 |
B |
$7.03 |
$45,695 |
D/D |
6,500 |
39,300 |
2.74 |
- |
|
| Horak Ivan D |
EVP-R&D & Chief Scien. Officer |
• – – |
2005-10-04 |
4 |
B |
$7.18 |
$39,490 |
D/D |
5,500 |
5,500 |
2.74 |
- |
|
| Buchalter Jeffrey H |
Chief Executive Officer |
• • – |
2005-06-10 |
4 |
B |
$5.75 |
$57,500 |
D/D |
10,000 |
88,234 |
2.81 |
- |
|
| Salisbury Robert C |
Director |
– • – |
2005-05-12 |
4 |
A |
$0.00 |
$0 |
D/D |
3,597 |
5,597 |
|
- |
|
| Salisbury Robert C |
Director |
– • – |
2005-05-12 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
2,000 |
|
- |
|
| Davit Paul Stephen |
EVP, Human ResourcesOfficer |
• – – |
2005-04-07 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
32,800 |
|
- |
|
| Delcampo Ralph |
EVP, Technical OperationsOffic |
• – – |
2005-04-07 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
32,601 |
|
- |
|
| Dixon Rosina B |
Director |
– • – |
2005-01-18 |
4 |
GD |
$0.00 |
$0 |
D/D |
825 |
55,433 |
|
- |
|
| Tooman Craig A |
Executive Vice President |
• – – |
2005-01-05 |
4 |
A |
$0.00 |
$0 |
D/D |
25,000 |
25,000 |
|
- |
|
| Renfro Phillip M |
Director |
– • – |
2005-01-04 |
4 |
A |
$0.00 |
$0 |
D/D |
1,896 |
1,896 |
|
- |
|
| Buchalter Jeffrey H |
Chief Executive Officer |
• • – |
2004-12-22 |
4 |
A |
$0.00 |
$0 |
D/D |
75,000 |
75,000 |
|
- |
|
| Micati Victor P |
Director |
– • – |
2004-11-11 |
4 |
A |
$0.00 |
$0 |
D/D |
1,566 |
1,566 |
|
- |
|
394 Records found
|
|
Page 15 of 16 |
|
|
